A research team combats antibiotic-resistant superbugs by administering antibiotics together with metformin.
Convolutional neural networks provide stronger predictive performances for pharmacological assays compared to traditional machine learning models.
Scientists are finding safer ways to keep drug-loaded microrobots attached to cancer tissue.
Researchers at Houston Methodist Research Institute discuss how quantitative, non-invasive imaging can aid in developing novel tools for diagnosis and therapy.
Antibiotic-resistant bacteria are becoming a major global threat. Novel antibacterial nanomaterials offer a solution.
Researchers at the University of Munich have demonstrated a conceptually novel nanocarrier strategy in which the nanoparticles are both the cargo and the carrier.
A new AI system can identify optimal combinations of drugs and dosages in a matter of days to help halt viral pandemics before they reach global scales.
Remdesivir, an anti-viral agent known to be effective against MERS, is already in human trials as researchers search for a treatment for COVID-19.
A nanocarrier that can deliver siRNA into the lungs is investigated for the treatment of severe asthma and other lung diseases.
RNA elements that are found in the genomes of numerous representatives within the same virus family provide new opportunities to expand the repertoire of targets for the development of antiviral therapy.
A blackboard of therapeutic innovation: Researchers seek to understand how antisense oligonucleotides can “erase” disorders.
The Lahann Lab at the University of Michigan discusses how nanomedicine benefits by bridging biology, engineering, and materials.